Anne Jenene Zurovec Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19965 Fm 3175, Lytle, TX 78052 Phone: 210-357-0395 |
Ms. Karla Elizabeth Bowman, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19965 Fm 3175, Lytle, TX 78052 Phone: 210-357-0395 Fax: 830-709-5493 |
Emma C. Garcia, LOT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19965 Fm 3175 N., Lytle, TX 78052 Phone: 210-357-0369 Fax: 210-357-0458 |
Kristen Lenee Ruiz, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19965 Fm 3175, Lytle, TX 78052 Phone: 210-357-0395 Fax: 830-709-5493 |
Mrs. Tawnya Ann Vogelsong, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19965 Fm 3175, Lytle, TX 78052 Phone: 210-357-0395 Fax: 830-709-5493 |
Lauri K. Staples, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19965 Fm 3175 North, Lytle, TX 78052 Phone: 210-357-0369 Fax: 210-357-0369 |
Angela G Lamanna, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19965 Fm 3175, Lytle, TX 78052 Phone: 210-357-0395 Fax: 830-709-5493 |
Jessie Sitka Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19965 Fm 3175, Lytle, TX 78052 Phone: 210-357-0335 |
Michelle Gamez Roiz, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 19965 Fm 3175, Lytle, TX 78052 Phone: 210-357-0395 Fax: 830-709-5493 |
News Archive
In this analysis of data from 20 studies conducted in China, Japan, South Korea, Singapore, Taiwan and India with more than 1 million participants, deaths associated with smoking continued to increase among men in Asia grouped by the years in which they were born.
Three-fourths of preschool-age children in the United States attend child care, and many are not getting enough outdoor physical activity, which may be due in part to parental and societal values about injury prevention and kindergarten readiness.
At the opening ceremony of the XVIII International Congress for Tropical Medicines and Malaria (ICTMM) and the XLVIII Congress of the Brazilian Society of Tropical Medicine in Rio de Janeiro, the Ministry of Health of Brazil signed a Cooperation and Technical Assistance Agreement with the Oswaldo Cruz Foundation (FIOCRUZ) and the Drugs for Neglected Diseases initiative (DNDi) Latin America, uniting the three actors into a strategic partnership to collaborate on research and development (R&D) for new therapies and diagnostics for neglected diseases.
Peregrine Pharmaceuticals, Inc. (PPHM) today reported publication of data in the online edition of the journal Current Cancer Therapy Reviews that supports the clinical potential of the company's novel brain cancer agent Cotara® for the treatment of patients with glioblastoma multiforme (GBM), the deadliest form of brain cancer. Cotara specifically targets cells at the center of brain tumors, so its radioactive payload is able to kill cancer cells while leaving healthy tissue largely unaffected. Cotara is currently being tested in a Phase II clinical trial in recurrent GBM patients.
› Verified 7 days ago